Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 76 for “"N-Myc"”.

  1. Identification of novel N-MYC interacting proteins reveals N-MYC interaction with TFIIIC

    N-MYC is a member of the human MYC proto-oncogene family, which comprises three transcription factors (C-, N- and L-MYC) that function in multiple biological processes. Deregulated expression of MYC proteins is linked to tumour initiation, maintenance and progression. For example, a large fraction …

    wurz-thes Repository record for Identification of novel N-MYC interacting proteins reveals N-MYC interaction with TFIIIC (opens in a new tab)

  2. TFIIIC subunits employ different modes of action for regulating N-MYC

    Amplification of N-MYC is a poor prognostic and survival marker of neuroblastoma. To broaden the scope of knowledge in N-MYC cancer biology, interactors of N-MYC should be investigated. TFIIIC complex was identified as a new protein interacting partner of N-MYC. TFIIIC is a core component of …

    wurz-thes Repository record for TFIIIC subunits employ different modes of action for regulating N-MYC (opens in a new tab)

  3. Utilisation of NMR to study N-myc TAD dynamics and interactions

    The myc family of proteins (c-, N- and L-myc) are transcription factors (TFs) responsible for maintaining the proliferative program in cells. 28% of tumours exploit these properties through deregulation of myc in various ways, which aids cancer through faster growth rates. Structural and …

    whiterose Download PDF for Utilisation of NMR to study N-myc TAD dynamics and interactions (opens in a new tab)

  4. The novel long noncoding RNA lncUSMycN in N-Myc-induced oncogenesis

    … of a 130 kb genomic DNA region containing the MYCN oncogene. While MYCN has been extensively investigated, it is unknown whether other genomic elements within the 130 kb amplicon play a role in neuroblastoma. In this study, I experimentally validated the novel long noncoding RNA up-stream of …

    unsw Repository record for The novel long noncoding RNA lncUSMycN in N-Myc-induced oncogenesis (opens in a new tab)

  5. N-myc oncogene expression in neuroblastoma is dependent on Sp1 and Sp3

    Regulation of N-myc oncogene expression is an important determinant of the biological behavior of neuroblastoma. The N-myc promoter contains several potential binding sites for transcription factors of the Sp1 family. Mutation of a CT-box motif contained within a 26 base pair region required for …

    hawaii Repository record for N-myc oncogene expression in neuroblastoma is dependent on Sp1 and Sp3 (opens in a new tab)

  6. Charakterisierung der Wechselwirkung zwischen N-Myc und Aurora-A im MYCN-amplifizierten Neuroblastom

    Im Neuroblastom ist die Amplifikation des MYCN-Gens, eines Mitglieds der MYC-Onkogenfamilie, mit einer ungünstigen Prognose assoziiert. Der von dem Gen kodierte Transkriptionsfaktor N-Myc ist für die Proliferation der MYCN-amplifizierten Neuroblastomzelllinien notwendig und seine Depletion oder …

    wurz-thes Repository record for Charakterisierung der Wechselwirkung zwischen N-Myc und Aurora-A im MYCN-amplifizierten Neuroblastom (opens in a new tab)

  7. Functional analysis of N-MYC downstream regulated gene 1 (NDRG1) in Oesophageal squamous cell carcinoma

    … we describe our work analysing the function of N-myc downstream regulated gene 1 (NDRG1, also known as Cap43 or Drg-1) in the neoplastic progression and maintenance of OSCC. Although NDRG1 has previously been implicated in breast, prostate, colon and liver carcinoma, the exact role of NDRG1 in …

    cape-town Repository record for Functional analysis of N-MYC downstream regulated gene 1 (NDRG1) in Oesophageal squamous cell carcinoma (opens in a new tab)

  8. Targeting Aurora-A and N-Myc in childhood cancer models using targeted protein degradation technology

    … functions is the stabilising effect on N-Myc. N-Myc is a member of the MYC family of transcription factors. High MYCN expression is a known risk factor for certain cancer types, in particular neuroblastoma. The first Aurora-A PROTAC, called JB170, was published in 2020. The aim of this …

    wurz-thes Repository record for Targeting Aurora-A and N-Myc in childhood cancer models using targeted protein degradation technology (opens in a new tab)

  9. Expression and Clinical Significance of the N-myc downstream regulated gene-1 in Hypopharyngeal Cancer

    "Expression and Clinical Significance of The N-myc downstream regulated gene-1 in Hypopharyngeal Cancer Objective. N-myc downstream regulated gene-1 (Ndrg-1), a potent metastasis suppressor gene, is identified as a gene that is up-regulated by the induction of differentiation in various cancer cell …

    ajou Repository record for Expression and Clinical Significance of the N-myc downstream regulated gene-1 in Hypopharyngeal Cancer (opens in a new tab) Embargoed until 9999-12-31

  10. A high-complexity lentiviral shRNA screen identifies synthetic lethal interactions with deregulated N-Myc in neuroblastoma cells

    In contrast to c-Myc, a deregulated expression of the MYCN gene is restricted to human neuroendocrine tumours. In most cases, the excessive activity of N-Myc results from a MYCN amplification. In neuroblastoma, amplification of MYCN is a predictor of poor prognosis and resistance to therapy. The …

    wurz-thes Repository record for A high-complexity lentiviral shRNA screen identifies synthetic lethal interactions with deregulated N-Myc in neuroblastoma cells (opens in a new tab)

  11. Targeting Transcription Factors in Neuroblastoma: Development of Aurora Kinase A/N-Myc Degraders and ID2 Chemical Probes

    … using targeted protein degradation. N-Myc overexpression is the most frequent driver in neuroblastoma. Unique features of N-Myc biology offer innovative approaches for developing chemical modulators of this oncogenic TF. For example, N-Myc is stabilized from proteolytic degradation in …

    umn Repository record for Targeting Transcription Factors in Neuroblastoma: Development of Aurora Kinase A/N-Myc Degraders and ID2 Chemical Probes (opens in a new tab)

  12. Identification of molecules able to interfere with the interaction between Aurora-A and N-Myc in Neuroblastoma

    … for the ~10% of all infant cancers. The MYCN gene amplification, coding for the N-Myc transcriptional factor, is an essential marker correlated with prognosis and progression. In these cells, another protein frequently implicated and overexpressed in cancer, the mitotic kinase Aurora-A, …

    greece Repository record for Identification of molecules able to interfere with the interaction between Aurora-A and N-Myc in Neuroblastoma (opens in a new tab)

  13. The Relationship Between N-myc Copy Number or Expression and Resistance to Therapy in Human Neuroblastoma Cell Lines

    The copy number of the N-myc oncogene provides a prognostic index for neuroblastoma. The mechanism for this is not known, but may be related to cellular resistance to radiation or cytotoxic drugs. Seven human neuroblastoma cell lines were used to investigate the relationship between N-myc copy …

    glasgow Download PDF for The Relationship Between N-myc Copy Number or Expression and Resistance to Therapy in Human Neuroblastoma Cell Lines (opens in a new tab)

  14. A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers

    … a subset of NEPC exhibits overexpression of the MYCN oncogene along with the loss of tumor-suppressing TP53 and RB1 activities. Unfortunately, N-MYC is structurally disordered with no binding pockets available on its surface, and so far, no clinically approved drug is available. Therefore, we …

    sask Repository record for A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers (opens in a new tab)

  15. Finding the Best Gene Candidate(s) as a Potential Therapeutic Target for N-MYC Overexpressing Neuroendocrine Prostate Cancer (NEPC)

    … regulate the development of NEPC cells is the N-MYC oncogene, along with the loss of tumor suppressors such as TP53 and RB1 (Lee et al., 2016). Resistance to current treatments results in the transformation of prostate cancer (PC) cells into Castration-resistant prostate cancer (CRPC), which at …

    sask Repository record for Finding the Best Gene Candidate(s) as a Potential Therapeutic Target for N-MYC Overexpressing Neuroendocrine Prostate Cancer (NEPC) (opens in a new tab)

  16. Elucidating the Physiologic and Prognostic Significance of N-Myc and STAT Interactor using Models of Mammary Development and Metastasis

    … of metastatic disease remain elusive. N-MYC and STAT Interactor (NMI) is a gene previously demonstrated by Devine et. al. to be downregulated with metastatic progression of breast cancer. However, due to the lack of a relevant genetic model, details of biological consequence of the loss …

    uab Repository record for Elucidating the Physiologic and Prognostic Significance of N-Myc and STAT Interactor using Models of Mammary Development and Metastasis (opens in a new tab)

Page 1 of 4